Abstract:Cannabidiol (CBD) is a safe and non-psychotropic phytocannabinoid with a wide range of potential therapeutic anti-inflamatory and antioxidant activities. Due to its lipophilicity, it is normally available dissolved in oily phases. The main aim of this work was to develop and characterize a new formulation of a microemulsion with potential anti-inflammatory and antioxidant activity for the topical treatment of inflammatory skin disorders. The microemulsion system was composed of a 20% CBD oil, which served as the hydrophobic phase; Labrasol/Plurol Oleique (1:1), which served as surfactant and cosurfactant (S/CoS), respectively; and an aqueous vegetal extract obtained from Sambucus ebulus L. (S. ebulus) ripe fruits, which has potential anti-oxidant and anti-inflammatory activity and which served as the aqueous phase. A pseudo-ternary phase diagram was generated, leading to the selection of an optimal proportion of 62% (S/CoS), 27% CBD oil and 11% water and, after its reproducibility was tested, the aqueous phases were replaced by the vegetal hydrophilic extract. The defined systems were characterized in terms of conductivity, droplet size (by laser scattering), compatibility of components (by differential scanning calorimetry) and rheological properties (using a rotational rheometer). The designed microemulsion showed good stability and slight pseudo-plastic behavior. The release properties of CBD from the oil phase and caffeic acid from the aqueous phase of the microemulsion were studied via in vitro diffusion experiments using flow-through diffusion cells and were compared to those of a CBD oil and a microemulsion containing only CBD as an active substance. It was found that the inclusion of the original oil in microemulsions did not result in a significant modification of the release of CBD, suggesting the possibility of including hydrophilic active compounds in the formulation and establishing an interesting strategy for the development of future formulations.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop and characterize a micro - emulsion containing cannabidiol (CBD) oil and water extract of elderberry (Sambucus ebulus) for external skin treatment of inflammatory skin diseases. Since CBD is highly lipophilic and usually dissolved in the oil phase, this limits its combined use with other hydrophilic molecules. Therefore, the researchers designed a new micro - emulsion system, aiming to enhance the anti - inflammatory effect of CBD by combining CBD oil and the water extract of elderberry with potential antioxidant and anti - inflammatory effects, and to provide new strategies for future formulations for the treatment of skin diseases. Specifically, the objectives of the paper include: 1. **Develop a new micro - emulsion**: Design a micro - emulsion containing 20% CBD oil and elderberry water extract to improve its stability and drug - release characteristics. 2. **Characterize the properties of the micro - emulsion**: Conduct a detailed characterization of the micro - emulsion through conductivity, particle - size distribution, component compatibility (differential scanning calorimetry) and rheological properties (rotary rheometer). 3. **Evaluate drug - release characteristics**: Through in - vitro diffusion experiments, study the release characteristics of CBD from the oil phase and caffeic acid from the water phase, and compare them with pure CBD oil and micro - emulsions containing only CBD. Through these studies, the authors hope to develop a micro - emulsion that can contain both lipophilic and hydrophilic active ingredients simultaneously, thereby providing a more effective topical treatment method for inflammatory skin diseases.

Development and Characterization of a Microemulsion Containing a Cannabidiol Oil and a Hydrophilic Extract from Sambucus ebulus for Topical Administration

Stability, Biofunctional, and Antimicrobial Characteristics of Cannabidiol -Isolate for the Design of Topical Formulations

Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study

Cutaneous Delivery and Biodistribution of Cannabidiol in Human Skin after Topical Application of Colloidal Formulations

Formulation Development and Evaluation of Cannabidiol Hot-Melt Extruded Solid Self-Emulsifying Drug Delivery System for Oral Applications

Formulation and in Vitro - Ex vivo evaluation of cannabidiol and Cannabidiol-Valine-Hemisuccinate loaded Lipid-Based nanoformulations for ocular applications

Development and characterization of nanostructured lipid carriers for cannabidiol delivery

Design and Characterization of Lipid-Surfactant-Based Systems for Enhancing Topical Anti-Inflammatory Activity of Ursolic Acid

Development and characterization of eucalyptol microemulsions for topic delivery of curcumin

Development and Optimization of a Topical Formulation with Castanea sativa Shells Extract Based on the Concept “Quality by Design”

Harnessing therapeutic deep eutectic solvents in self-emulsifying systems to improve CBD delivery

Synthesis of (‐)‐Cannabidiol (CBD), (‐)‐Δ9‐ and (‐)‐Δ8‐Tetrahydrocannabinols, Encapsulation of CBD with Nanoparticles for Controlled Delivery and Biological Evaluation

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences

Preparation and In Vitro Characterization of Alkyl Polyglucoside-Based Microemulsion for Topical Administration of Curcumin

Fabrication and characterization of a cannabidiol-loaded emulsion stabilized by a whey protein-maltodextrin conjugate and rosmarinic acid complex

A Nano-Based Approach to Deliver Satureja thymbra Essential Oil to the Skin: Formulation and Characterization

In situ forming PLA and PLGA implants for the parenteral administration of Cannabidiol

Promising Nanocarriers to Enhance Solubility and Bioavailability of Cannabidiol for a Plethora of Therapeutic Opportunities

Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS

Exploring Cannabidiol (CBD) and Cannabigerol (CBG) Safety Profile and Skincare Potential

Microemulsion-based Hydrogel Formulation of Ibuprofen for Topical Delivery.